Skip to main content
Figure 3 | Multidisciplinary Respiratory Medicine

Figure 3

From: Evaluation of reactive oxygen metabolites in patients with non-small cell lung cancer after chemotherapy

Figure 3

ROMs levels (U. CARR) before and after 2ndcourse of chemotherapy in patients with non-small cell lung cancer classified as responders (complete response/partial response) and non-responders (stable disease/progressive disease). Individual paired data and mean ± SD are shown. a) A significant decrease in ROMs level is observed in responders (p = 0.014, paired t-test). b) No significant difference in ROMs levels is found in nonresponders (p = 0.387, paired t-test).

Back to article page